Cure8 news brief
This study maps cell-level signatures in newly diagnosed pediatric Crohn’s and links them to later severity and responses to anti-TNF treatment, which could help predict which children will respond to biologic therapy and who may develop more severe, treatment-resistant disease.
Pediatric patients and their caregivers, clinicians treating childhood Crohn’s, researchers using single-cell approaches or studying IBD biomarkers, and patients on or considering anti-TNF biologics.
Researchers used single-cell RNA sequencing on diagnostic small-intestine biopsies from children with newly diagnosed Crohn’s disease, built a pediatric Crohn’s cellular atlas (pediCD), and linked diagnostic cell states to later disease severity and response to anti-TNF therapy.
They also created a bioinformatics tool (ARBOL) for identifying cell-state trees and compared pediatric data with adult Crohn’s single-cell data. The study identifies proinflammatory immune-cell increases and loss of specialized epithelial/metabolic cell subsets as features of more severe disease and treatment-resistant states.
The results come from a modest-sized, geographically limited pediatric cohort and some findings were integrated with adult data; the authors note limits in cohort size, follow-up duration, and inability to assess genetic, microbiome, or broad environmental factors. The paper was first a reviewed preprint and is now the version of record in eLife.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study suggests anti-TNF failure in Crohn's may be driven by pre-existing cytokine interaction networks and loss of regulatory feedback, which could help explain why some patients don't respond to TNF-blocking...
Identifying baseline cellular states that predict disease course or response to anti‑TNF could help researchers develop predictive biomarkers and new therapeutic strategies for pediatric Crohn’s disease.
Because it describes a severe new Crohn’s disease case temporally linked to COVID‑19, patients and clinicians should be aware that persistent or worsening GI symptoms after SARS‑CoV‑2 infection may merit investigation;...
